Perseus Proteomics Inc. reported impairment loss for the first quarter of the fiscal year 2023. For the quarter, the company booked impairment loss of JPY 129,845,000 for its non-current assets in accordance with the Accounting Standard for Impairment of Fixed Assets.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
311 JPY | -6.04% | -7.44% | -49.68% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-49.68% | 26.35M | |
+0.10% | 91.42B | |
+2.76% | 41.08B | |
-9.06% | 34.26B | |
+54.31% | 25.27B | |
-16.61% | 15.27B | |
-9.14% | 12.81B | |
-12.11% | 11.6B | |
-43.61% | 11.42B | |
+6.22% | 9.16B |
- Stock Market
- Equities
- 4882 Stock
- News Perseus Proteomics Inc.
- Perseus Proteomics Inc. Reports Impairment Loss for the First Quarter of the Fiscal Year 2023